Drug Profile
Scopolamine transmucosal - Anesta
Alternative Names: Oral transmucosal system - scopolamine; OTS - scopolamine; Scopolamine oral transmucosal systemLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Anesta Corporation
- Class Antidepressants; Antiemetics; Antispasmodics; Hypnosedatives; Mydriatics; Small molecules; Tropanes
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Nausea and vomiting
Most Recent Events
- 23 Aug 2006 Discontinued - Phase-I for Emesis in USA (Transmucosal)
- 01 Nov 2000 Anesta has been acquired by Cephalon
- 24 Jul 2000 Phase-I clinical trials for Emesis in USA (Transmucosal)